眼药水市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00011308
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 188
Buy Now

【研究报告】2022年滴眼液市场规模为157.9327亿美元,预计到2030年将达到237.8845亿美元,预计预测期内复合年增长率为5.3%。

> 市场洞察和分析师观点:

滴眼剂是含有用于治疗各种眼部疾病的药物的盐溶液。有时它们不含任何药物,用于冲洗异物或润滑眼睛。由于眼部疾病患病率的增加,对青光眼滴眼液、过敏滴眼液、干眼滴眼液、白内障滴眼液的需求量不断增加。由于灰尘和污染导致的眼部感染增加,以及因数字屏幕时间过长而导致眼部疾病。此外,由于眼部肌肉衰弱,老年人口白内障和青光眼病例不断增加,加上公司的战略举措,正在推动全球滴眼剂市场的增长。然而,一些滴眼剂的无菌问题或包装不当导致产品召回,阻碍了市场增长。

增长动力和机遇:

眼科疾病的发病率,例如导致视力损害的糖尿病性视网膜病变、青光眼和干眼症在人群中呈上升趋势,尤其是在发达国家。干眼症是由多种因素引起的,这些因素会导致不适、刺激和视力障碍。根据 2020 年 4 月在美国进行的一项“全国健康与健康调查”研究,约有 1640 万人被诊断患有干眼症。数据还表明,18-34 岁人群中的患病率激增了 2.7%。据 Novaliq GmbH 称,目前约有 1300 万欧洲人和约 1700 万美国人患有干眼病。

糖尿病视网膜病变代表微血管终末器官损伤。它从非增殖性糖尿病视网膜病变阶段进展为增殖性糖尿病视网膜病变。随着疾病的进展,相关的糖尿病性黄斑水肿也可能变得明显。根据美国眼科学会发表的一篇文章,预计到 2030 年,全球将有 1.91 亿人患有糖尿病视网膜病变。据 Medscape 称,美国约有 700,000 人患有增殖性糖尿病视网膜病变,每年新增病例约 65,000 例。

根据世界卫生组织 (WHO) 2022 年发表的一篇文章,全球约有 22 亿人患有近视或远视视力障碍。视力障碍的主要原因是白内障(约 9400 万例)和未矫正的屈光不正(约 8840 万例)。医生通常会开眼药水来治疗和预防眼科疾病。因此,眼科疾病患病率的不断上升,推动了眼药水市场的增长。

近年来,人们采取了各种措施和努力来提高人们对眼病的认识和教育,促使患者获得合适的药物和治疗。 2017年,美国国家眼科研究所(NEI)启动了一项新的眼睛健康意识计划“Write the Vision”,以提高人们对眼睛健康的认识,特别是针对非裔美国消费者。 “书写愿景”计划每月向大量组织提供资源,使他们能够在其服务的社区中促进健康视力并预防视力丧失和失明。根据国家眼健康教育计划(NEI 的一部分),非裔美国人更容易患眼病。如果不及时治疗,这些眼部疾病会导致视力丧失。

Sightsavers 是一个国际非政府组织,致力于在发展中国家治疗和预防眼部疾病。印度大量人口居住在农村地区,对眼病的认识有限或根本没有。 Sightsavers 旨在通过其农村眼健康计划提高人们的认识,提供高质量的眼健康服务,并消除农村人口中可避免的失明。此外,世卫组织于2019年启动了全民健康覆盖和眼保健:促进国家行动,旨在提供实用的分步指导,支持世卫组织会员国规划和实施世卫组织世界报告的建议关于视力。世界卫生组织发起此次活动的目的是提供以人为本的综合眼保健服务。此外,2020 年印美合作视觉研究计划的重点是推进对于理解、预防和治疗致盲眼病、视力障碍及相关并发症至关重要的科学和技术。印度生物技术部和美国 NEI 资助了该研究项目。因此,增加眼保健研究资金可能会为滴眼剂市场参与者提供增长机会。

战略见解

报告细分和范围:

“全球滴眼剂市场”按技术、类型、分销渠道和地理位置进行细分。根据类型,滴眼剂市场分为抗生素、激素、人工泪液等。按用途,滴眼剂市场分为眼病、眼保健等。眼病细分为干眼症、青光眼、白内障等。根据购买模式,滴眼剂市场分为处方药和非处方药。从地理上看,滴眼剂市场分为北美(美国、加拿大和墨西哥)、欧洲(德国、法国、意大利、英国、俄罗斯和欧洲其他地区)、亚太地区(澳大利亚、中国、日本、印度) 、韩国和亚太地区其他地区)、中东和非洲(南非、沙特阿拉伯、阿联酋以及中东和非洲其他地区)以及南美洲和中美洲(巴西、阿根廷以及中南部和中部其他地区)

细分分析:

根据类型,滴眼剂市场分为抗生素、激素、人工泪液等。抗生素细分市场在 2022 年占据最大的市场份额。激素细分市场预计在预测期内复合年增长率最高。抗生素滴眼液是医生开出的用于治疗抗菌感染的液体药物。一旦抗生素滴眼液接触到眼睛表面,它就会渗透到眼睛的多个组织层并开始对抗感染。在大多数情况下,抗生素滴眼液可以立即缓解病情。大多数抗生素滴眼液都是安全的,副作用也很小。

根据美国眼科学会的数据,外用抗生素(滴眼液或药膏)对病毒性或真菌性角膜炎或结膜炎无效。由于抗生素滴眼液在纠正睑板腺功能障碍时提供的好处,与抗生素滴眼液治疗相关的好处预计将在预测期内推动市场扩张。

滴眼液市场,按类型 - 2022 2030年

根据应用,滴眼剂市场分为眼病、眼保健等。眼病细分为干眼症、青光眼、白内障等。到 2022 年,眼科疾病领域占据最大的市场份额。预计眼科护理领域在预测期内的复合年增长率最高。眼部疾病或病症有很多种。根据世界卫生组织的数据,三种最具威胁的眼部疾病或病症是糖尿病性视网膜病变、青光眼和年龄相关性黄斑变性。除了这些疾病之外,屈光不正也会造成严重的视力损害。年龄、医疗保健不当、激素水平变化和遗传性疾病等问题也可能导致视力丧失或视力低下。据世界卫生组织称,未矫正的屈光不正和白内障是视力丧失和失明的主要原因。这是一种影响数百万人的普遍疾病。 2020 年,全球估计有 1520 万名 50 岁以上的人失明,另有 7880 万人因白内障而患有中度至重度视力障碍 (MSVI)。通常,患者在白内障手术后使用眼药水至少一个月。在第一周,患者必须每天滴眼药水数次。按规定使用眼药水对于保护眼睛健康至关重要。白内障手术后,大多数人需要使用药物眼药水来预防炎症和感染。佩戴隐形眼镜可能会导致或加重干眼症状。人们可以使用眼药水来减轻症状,因为眼药水有助于润滑眼睛表面。有许多人工泪液或润滑滴眼液不含任何防腐剂或其他化学物质。这些滴眼液以“不含防腐剂”或“用于隐形眼镜”的名义销售,以表明与隐形眼镜一起使用的安全性。

根据购买模式,滴眼剂市场分为处方药和非处方药。处方药细分市场将在 2022 年占据更大的市场份额,预计在预测期内市场复合年增长率将更高。当患者长时间使用现有的非处方 (OTC) 药物仍得不到结果时,就去看眼科医生。专家开出的处方滴眼液可以治疗干眼症等疾病,并降低青光眼患者的眼压。医生开出的抗生素滴眼液可治疗细菌性眼部感染。 Restasis(环孢素眼用)滴眼液被批准用于治疗干眼病(称为干燥性角结膜炎)。此外,许多药物可用于降低青光眼患者的眼压。用于这些目的的常用滴眼剂是前列腺素类似物,例如拉坦前列素、曲伏前列素、比马前列素和他氟前列素; β-受体阻滞剂,例如噻吗洛尔和倍他洛尔;和 α-2 肾上腺素能激动剂,例如溴莫尼定。处方药的发展将在未来几年继续推动市场发展。 Vuity 是美国食品药品监督管理局 (FDA) 批准的首款用于治疗老花眼的眼药水,于 2021 年 12 月上市。老花眼更常见于 40 岁及以上的人群。 Vuity 为数百万患有与年龄相关的视力模糊的美国人更换了老花镜。该处方药利用眼睛的自然能力来缩小瞳孔尺寸。因此,此类发展预计将加速处方药领域的滴眼剂市场增长。

区域分析:

从地理上看,滴眼剂市场分为五个关键区域:北美、欧洲、亚太地区、南美洲和中美洲、中东和非洲。 2022年,北美在全球滴眼剂市场中占据最大份额,预计亚太地区在预测期内的复合年增长率最高。干眼病在美国是一种常见但诊断不足的疾病。不断增长的老年人口进一步引发了干眼病的流行。根据美国疾病控制与预防中心 (CDC) 的数据,黄斑变性、白内障、糖尿病性视网膜病变和青光眼等与年龄相关的眼病是美国失明和低视力的主要原因。该国报告的其他常见眼部疾病包括弱视和斜视。随着人口老龄化和年轻人接受屈光手术频率的增加,预计到 2030 年,干眼症将影响多达 279 万美国男性。2021 年 1 月,Kala Pharmaceuticals Inc. 推出了 EYSUVIS 0.25%(依碳氯替泼诺眼用混悬液)用于短期(最多 2 周)治疗干眼病的体征和症状。 EYSUVIS 现已在美国所有国家和地方药品分销中心上市。

美国是北美滴眼剂市场最大且增长最快的国家。该国的市场归因于人们干眼病发病率的增加。美国有多家公司提供不同的眼药水和镜片来治疗干眼症。此外,不断增长的医疗保健支出有利于美国滴眼液市场的增长。

亚太地区市场的增长归因于澳大利亚、澳大利亚、和印度。印度人口众多,过敏和感染等与眼睛相关的问题也很普遍。它们广泛用于治疗常见的眼部疾病,如干燥、发红、瘙痒和结膜炎。此外,还使用专门的眼药水来治疗青光眼、白内障和其他严重的眼部疾病。印度的滴眼剂市场由国内和国际制药公司组成。在该国流行的一些知名国内品牌包括 Sun Pharmaceutical Industries Ltd、Cipla Ltd、Lupin Limited 和 Dr. Reddy's Laboratories。爱尔康、艾尔建、诺华和博士伦等国际公司也在印度市场占有一席之地。此外,政府医院和诊所经常以补贴价格提供眼药水,使普通大众更容易获得。

行业发展和未来机遇:

政府采取的各种举措全球滴眼液市场的主要参与者如下:

2023 年 7 月,博士伦公司从 Johnson & Johnson Vision 收购了 Blink 滴眼液和隐形眼镜滴液产品线。此次战略收购是该公司致力于提高眼科非处方药 (OTC) 消费者便利性的最新例证。 2023 年 6 月,博士伦公司与诺华公司达成最终协议,根据该协议,博士伦公司将收购 XIIDRA (lifitegrast)眼药水)5%,一种非类固醇滴眼液,专门批准用于治疗干眼病 (DED) 的体征和症状,重点关注与干眼相关的炎症。 2022 年 3 月,Akorn Operating Company LLC 完成了之前宣布的 7 种药物的销售Théa Pharma 的品牌眼科产品。根据该协议,Théa Pharma 收购了七种产品,包括成熟的青光眼疗法 Zioptan、Cosopt、Cosopt PF 和 Betimol,以及 Azasite、Akten 和眼表修复剂 AcellFX。COVID-19 影响:

在 COVID-19 大流行之前,滴眼剂市场正在经历稳定增长,并受到影响其动态的各种因素的影响。新冠疫情后对滴眼剂市场的影响不断变化,并且可能因不同国家的具体情况而异。 COVID-19 大流行凸显了整体健康的重要性,包括眼睛健康。人们对个人健康和卫生的日益关注可能会导致人们对眼睛护理的认识提高,从而导致对滴眼剂产品的需求更大。此次疫情加速了数字医疗解决方案的采用,包括远程医疗、远程咨询和医疗建议。这种趋势可能会在新冠疫情结束后持续下去,影响患者获得眼科护理服务的方式,并可能影响眼药水的分发和处方。疫情期间,远程工作和在线活动激增,导致屏幕时间增加和潜在的眼睛疲劳。新冠疫情过后,远程工作或混合模式的持续可能会维持对解决数字眼疲劳的眼药水的需求。

竞争格局和主要公司:

一些全球滴眼液市场的知名参与者包括 Akorn Operating Company LLC、Alcon AG、辉瑞 Inc、Prestige Consumer Healthcare Inc.、乐敦制药有限公司、Sager Pharma Kft、Similasan Corp、AbbVie Inc、Bausch & Lomb Inc 和 Biomedica Pvt有限公司这些公司专注于新产品发布和地域扩张,以满足全球不断增长的消费者需求,并增加其专业产品组合的产品范围。他们在全球范围内拥有广泛的影响力,这使他们能够为大量客户提供服务,从而增加他们的市场份额。该报告提供了滴眼剂市场的趋势分析,强调了各种参数,例如技术进步、市场动态和竞争格局分析全球领先的市场参与者。
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which type segment led eye drops market?

Based on type, the eye drops market is segmented into antibiotics, hormones, artificial tears, and others. The antibiotics segment held a larger market share in 2022. However, the hormones segment is anticipated to register a higher CAGR during the forecast period.

Which application segment held the largest revenue (US$ Mn) in the eye drops market?

Based on application, the eye drops market is segmented into eye diseases, eye care, and others. The eye diseases segment is further sub-segmented into dry eye, glaucoma, cataract, and others. The eye diseases segment held a larger market share in 2022. However, the eye care segment is anticipated to register a highest CAGR during the forecast period.

What is meant by the eye drops market?

Eye drops are most often saline solutions with medications in them to treat various conditions of the eye. Sometimes, they contain no medication and are meant to lubricate the eyes or to rinse out foreign bodies. In an injured eye, artificial tears also promote surface healing, increase comfort by reducing the feeling of a surface scratch and flush out any residual contaminating or injurious particles. They prevent further damage by keeping the eye lubricated. Anti-allergic drops alleviate the burning and stinging of the eyes that is so common with allergies. During allergy season, this can mean the difference between complete misery and moderate comfort. The use of medicated eye drops reduces the chance of systemic side effects from the drugs used when applied correctly. Glaucoma drops reduce the risk of blindness in this condition by relieving the pressure inside the eye which could otherwise harm the sensitive retina.

What is the regional market scenario of the eye drops market?

Global eye drops market is segmented by region into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is likely to continue its dominance in the eye drops market during 2022–2028. The US holds the largest share of the market in North America and is expected to continue this trend during the forecast period.

What are the driving factors for the eye drops market across the globe?

The rising prevalence of ophthalmic diseases and high incidence of age-related eye diseases are the key driving factors behind the market development.

Who are the key players in the eye drops market?

Companies operating in the market are Akorn Operating Company LLC, Alcon AG, Pfizer Inc, Prestige Consumer Healthcare Inc., Rohto Pharmaceutical Co Ltd, Sager Pharma Kft, Similasan Corp, AbbVie Inc, Bausch & Lomb Inc, and Biomedica Pvt Ltd.

The List of Companies - Eye Drop Market

  1. Akorn Consumer Health
  2. Alcon AG
  3. AbbVie
  4. Bausch + Lomb
  5. Biomedica Pvt Ltd
  6. Pfizer
  7. Prestige Consumer Healthcare
  8. Rohto Pharmaceuticals
  9. Sager Pharma
  10. Similasan Corporation

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports